Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers
Authors
Keywords
-
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-26
DOI
10.1007/s10585-021-10075-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer transcriptomic profiling from rapidly enriched circulating tumor cells
- (2020) Gareth J. Morrison et al. INTERNATIONAL JOURNAL OF CANCER
- Looking for a Better Characterization of Triple-Negative Breast Cancer by Means of Circulating Tumor Cells
- (2020) Manuel Abreu et al. Journal of Clinical Medicine
- Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
- (2019) Klaus Pantel et al. CLINICAL CHEMISTRY
- Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
- (2019) Aleksandra Markiewicz et al. Cancers
- N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
- (2019) Adeline Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- E-cadherin is required for metastasis in multiple models of breast cancer
- (2019) Veena Padmanaban et al. NATURE
- Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
- (2019) Sarah Bonk et al. Oncotarget
- Clinical utility of emerging biomarkers in prostate cancer liquid biopsies
- (2019) Emmy Boerrigter et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- A gene regulatory network to control EMT programs in development and disease
- (2019) Hassan Fazilaty et al. Nature Communications
- CTCs Expression Profiling for Advanced Breast Cancer Monitoring
- (2019) Thais Pereira-Veiga et al. Cancers
- Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics
- (2018) Serban Negoita et al. CANCER
- Profiling Prostate Cancer Therapeutic Resistance
- (2018) Cameron Wade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
- (2018) Glenn Heller et al. JOURNAL OF CLINICAL ONCOLOGY
- Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature
- (2018) Udit Singhal et al. MOLECULAR CANCER RESEARCH
- CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
- (2018) Filipa Lynce et al. PHARMACOLOGY & THERAPEUTICS
- Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
- (2018) Andreas Josefsson et al. Oncotarget
- Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
- (2018) Adam Sharp et al. JOURNAL OF CLINICAL INVESTIGATION
- Non-redundant functions of EMT transcription factors
- (2018) Marc P. Stemmler et al. NATURE CELL BIOLOGY
- EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients
- (2018) Sanne de Wit et al. Oncotarget
- Treatment of Metastatic Prostate Cancer in 2018
- (2018) Chung-Han Lee et al. JAMA Oncology
- Clinical significance of epithelial-mesenchymal transition markers in prostate cancer
- (2017) Sandy Figiel et al. HUMAN PATHOLOGY
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy
- (2017) Kristina E. Aaltonen et al. Oncotarget
- Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients
- (2017) Luis León-Mateos et al. Oncotarget
- Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications
- (2017) Xiao-Xiang Jie et al. Oncotarget
- MYC Is a Major Determinant of Mitotic Cell Fate
- (2015) Caroline Topham et al. CANCER CELL
- Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer
- (2015) Miguel Ángel Climent et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells
- (2015) Wendy Onstenk et al. EUROPEAN UROLOGY
- Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
- (2015) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Spatial genomic heterogeneity within localized, multifocal prostate cancer
- (2015) Paul C Boutros et al. NATURE GENETICS
- Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy
- (2014) Lei Chang et al. CANCER AND METASTASIS REVIEWS
- Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
- (2014) Amir Goldkorn et al. JOURNAL OF CLINICAL ONCOLOGY
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells
- (2013) Thippeswamy Gulappa et al. CANCER LETTERS
- Validation and clinical utility of prostate cancer biomarkers
- (2013) Howard I. Scher et al. Nature Reviews Clinical Oncology
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Epithelial Cell Adhesion Molecule-positive Circulating Tumor Cells as Predictive Biomarker in Patients With Prostate Cancer
- (2013) Robert J. Amato et al. UROLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Metastatic Progression of Prostate Cancer and E-Cadherin
- (2011) Aaron P. Putzke et al. AMERICAN JOURNAL OF PATHOLOGY
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Promotion of direct reprogramming by transformation-deficient Myc
- (2010) M. Nakagawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
- (2009) Howard I Scher et al. LANCET ONCOLOGY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now